I'm getting bombarded with "Reply from XXX" messag
Post# of 36536
(Total Views: 305)
Posted On: 07/29/2021 5:33:28 PM
I'm getting bombarded with "Reply from XXX" messages, so here's my thoughts:
Balleroni, I certainly respect your opinions but disagree with them (much as with Hylander's). Here's why:
Joe is not GNBT: I believe he is - without Joe, GNBT was a bankrupt company that I was writing off as losses against other gains. Joe gathered the talent of the folks running NGIO, Excellagen, and all the other initiatives, including stock splits and dividends. While taking longer than we hoped, Joe is solely responsible for GNBT even having those future potential revenue streams. And since so far, no one of his management picks has bolted from his vision, I've got to believe they continue to be viable with potential to be successes in the future.
$5k for a PR is ok if it boosts pps: But they haven't, and those are PRs with good news. Like getting payment from China, getting a positive response from the FDA on the pre-IND, getting the GMP certification, getting big names committed to produce the vaccine, etc. Do you really think a PR that states 'we're delayed because of X,Y or Z' will boost the pps when other PRs don't? I don't think so - in fact, I would expect the pps to further go down on the "we're delayed" portion of the PR.
Dilution is not being used wisely: Joe has pasted this together with string, duct tape and spit. How else is he going to make this a going concern without dilution? Covid probably delayed any shot at revenues for at least a year; but he had to keep the company open. Raising money through stock sales is about the only option available.
And on that same note, we're still only at 120 million shares (+ or -). That is not horrible compared to many other biotechs that are raising money through share sales. I credit Joe with judiciously selling shares based on what he needs at the time, not looking too far ahead. And that also signals to me Joe still believes there are revenues in the near future, which also helps keeping the dilution to a minimum.
Hylander - I understand your frustration with "communication", but if Joe has nothing to share that furthers the process, why share it when it costs the company 20,000 shares of stock dilution? My point is if you have no faith that Joe is doing anything "behind the scenes" other than sitting around not communicating, then it's probably in your best interest to no longer be an investor. I believe Joe is doing everything he can control behind the scenes, so I remain positive about the prospects of the company - that is what makes a market. But in my mind, spending money to say "we're waiting on the FDA" or "China hasn't paid us this amount yet, but we are sure they are going to" isn't fiscally responsible right now. Both messages have little chance of increasing pps, and as I mentioned above, I think they might even do further damage.
So I'm ok with waiting, because I think Joe is still working hard to advance both the IND submission and the IPO. It appears to me you don't. I'm not telling you to sell, I'm just asking, with those beliefs in the CEO of the company, why are you still invested?
Just my thoughts/opinions. Hopefully for you guys, this time I really will stay away.
Balleroni, I certainly respect your opinions but disagree with them (much as with Hylander's). Here's why:
Joe is not GNBT: I believe he is - without Joe, GNBT was a bankrupt company that I was writing off as losses against other gains. Joe gathered the talent of the folks running NGIO, Excellagen, and all the other initiatives, including stock splits and dividends. While taking longer than we hoped, Joe is solely responsible for GNBT even having those future potential revenue streams. And since so far, no one of his management picks has bolted from his vision, I've got to believe they continue to be viable with potential to be successes in the future.
$5k for a PR is ok if it boosts pps: But they haven't, and those are PRs with good news. Like getting payment from China, getting a positive response from the FDA on the pre-IND, getting the GMP certification, getting big names committed to produce the vaccine, etc. Do you really think a PR that states 'we're delayed because of X,Y or Z' will boost the pps when other PRs don't? I don't think so - in fact, I would expect the pps to further go down on the "we're delayed" portion of the PR.
Dilution is not being used wisely: Joe has pasted this together with string, duct tape and spit. How else is he going to make this a going concern without dilution? Covid probably delayed any shot at revenues for at least a year; but he had to keep the company open. Raising money through stock sales is about the only option available.
And on that same note, we're still only at 120 million shares (+ or -). That is not horrible compared to many other biotechs that are raising money through share sales. I credit Joe with judiciously selling shares based on what he needs at the time, not looking too far ahead. And that also signals to me Joe still believes there are revenues in the near future, which also helps keeping the dilution to a minimum.
Hylander - I understand your frustration with "communication", but if Joe has nothing to share that furthers the process, why share it when it costs the company 20,000 shares of stock dilution? My point is if you have no faith that Joe is doing anything "behind the scenes" other than sitting around not communicating, then it's probably in your best interest to no longer be an investor. I believe Joe is doing everything he can control behind the scenes, so I remain positive about the prospects of the company - that is what makes a market. But in my mind, spending money to say "we're waiting on the FDA" or "China hasn't paid us this amount yet, but we are sure they are going to" isn't fiscally responsible right now. Both messages have little chance of increasing pps, and as I mentioned above, I think they might even do further damage.
So I'm ok with waiting, because I think Joe is still working hard to advance both the IND submission and the IPO. It appears to me you don't. I'm not telling you to sell, I'm just asking, with those beliefs in the CEO of the company, why are you still invested?
Just my thoughts/opinions. Hopefully for you guys, this time I really will stay away.
(5)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼